Steven Cohen's ALT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 665,289 shares of Altimmune, Inc. (ALT) worth $2.05 M, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ALT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 1.25 M shares. Largest reduction occurred in Q3 2021, reducing 1.56 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Altimmune (ALT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Altimmune (ALT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +665,289 | New Buy | 665,289 | $3.08 |
| Q4 2025 | -476,926 | Sold Out | 0 | $0.00 |
| Q3 2025 | +476,926 | New Buy | 476,926 | $3.77 |
| Q2 2024 | -7,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | -1.24 M | Reduce 99.39% | 7,600 | $10.18 |
| Q4 2023 | +1.25 M | New Buy | 1.25 M | $11.25 |
| Q2 2023 | -13,987 | Sold Out | 0 | $0.00 |
| Q1 2023 | +13,987 | New Buy | 13,987 | $4.22 |
| Q3 2022 | -609,100 | Sold Out | 0 | $0.00 |
| Q2 2022 | +609,100 | New Buy | 609,100 | $11.70 |
| Q3 2021 | -1.56 M | Sold Out | 0 | $0.00 |
| Q2 2021 | +1.56 M | New Buy | 1.56 M | $9.85 |
Steven Cohen's Altimmune Investment FAQs
Steven Cohen first purchased Altimmune, Inc. (ALT) in Q2 2021, acquiring 1,564,654 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Altimmune, Inc. (ALT) for 12 quarters since Q2 2021.
Steven Cohen's largest addition to Altimmune, Inc. (ALT) was in Q2 2021, adding 1,564,654 shares worth $15.41 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 665,289 shares of Altimmune, Inc. (ALT), valued at approximately $2.05 M.
As of the Q1 2026 filing, Altimmune, Inc. (ALT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Altimmune, Inc. (ALT) was 1,564,654 shares, as reported at the end of Q2 2021.